JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 7 507-510
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halpern, S.
Right arrow Articles by Ashburn, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halpern, S.
Right arrow Articles by Ashburn, W.

131I Thyroid Uptakes: Capsule Versus Liquid

S. Halpern, N. Alazraki, R. Littenberg, S. Hurwitz, J. Green, J. Kunsa and W. Ashburn

University of California, San Diego, School of Medicine, La Jolla, California and Veterans Administration Hospital, La Jolla, California

Correspondence: For reprints contact: Samuel E. Halpern, Div. of Nuclear Medicine, University Hospital of San Diego County, 225 West Dickinson St., San Diego, Calif. 92103.

ABSTRACT

Studies were performed that indicate that normal, healthy individuals have a lower thyroidal uptake of 131I following a capsule dose of 131I than they do following a liquid dose. Two possible mechanisms for this are offered, the first being the variable amount of time it takes for the ingested capsule to dissolve completely and the second being the formation of iodine gelatin complexes in the GI tract. In the latter case, the labeled iodine would not appear to be in a form that would allow it to be trapped by the thyroid gland. It is recommended that if early uptake values are important in assessing the clinical state of the patient, liquid 131I be used in preference to capsulized 131I. Furthermore, the possibility exists that the fall in 131I uptake values noted in the past several years may in part be due to the widespread use of 131I capsules.




This article has been cited by other articles:


Home page
JNMHome page
M.-D. Yu, W.-S. Huang, C.-C. Cherng, and S. M. Shaw
The Effect of Formulation on Reduced Radioiodide Thyroid Uptake
J. Nucl. Med., January 1, 2002; 43(1): 56 - 60.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.